This work demonstrated reductions in behavioral responses to peripheral inflammation after i.t. injection of a drug that reversed obesity-induced PPARα downregulation in spinal cord, even though the treatment did not affect metabolic parameters. Here, PPARA is linked to obesity due to melanocortin 4 receptor deficiency.